This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chidsey, C. A. Articles by Zanchetti, A. Search for Related Content PubMed PubMed Citation Articles by Chidsey, C. A. Articles by Zanchetti, A.

Circulation, Vol 52, 313-318, Copyright © 1975 by American Heart Association

ARTICLES

Studies of the absorption and removal of propranolol in hypertensive patients during therapy

CA Chidsey, P Morselli, G Bianchetti, A Morganti, G Leonetti and A Zanchetti

The variability of plasma propranolol concentrations has been determined in a large group of patients being treated with the drug. Although the average patient achieved a therapeutic plasma level with 160 mg/day, there was marked interpatient variation. This was found to be primarily the result of differences in effective absorption of the drug, which averaged 46% of the oral dose but ranged from 20 to 80%. Propranolol disappeared from plasma with a half-life of 4.7 hours and its removal appeared to follow dose independent kinetics with no evidence of saturation of hepatic metabolism. The derived pharmacokinetic values of volume of distribution and clearance rate have been used to provide guidelines for initiating propranolol therapy intravenously, and the schedule of 8 mg as a loading dose and 0.02 mg/min as a sustaining dose has been suggested.